Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (41-50 of 287) with videos related to

Pageof 29
Sort By:
Current Gastroenterology Reports|November 14, 2008
Optimizing treatment of inflammatory bowel diseases with biologic agentsGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Current Opinion in Gastroenterology|June 1, 2012
Classification of inflammatory bowel disease: the old and the newSeverine Vermeire, Gert Van Assche, Paul Rutgeerts
Nature Clinical Practice. Gastroenterology & Hepatology|December 6, 2005
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseasesSéverine Vermeire, Gert Van Assche, Paul Rutgeerts
Expert Opinion on Medical Diagnostics|March 19, 2013
Role of biomarkers in the diagnosis of inflammatory bowel diseaseSeverine Vermeire, Gert Van Assche, Paul Rutgeerts
Core Evidence|January 12, 2011
Infliximab: the evidence for its place in therapy in ulcerative colitisGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Gut|December 17, 2009
Predicting the response to infliximab from trough serum levelsPaul Rutgeerts, Severine Vermeire, Gert Van Assche
Inflammatory Bowel Diseases|January 19, 2007
Endoscopic therapy of strictures in Crohn's diseaseGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Inflammatory Bowel Diseases|September 26, 2008
What is the role of endoscopy in predicting Crohn's disease relapse or course?Paul Rutgeerts, Severine Vermeire, Gert Van Assche
Current Opinion in Gastroenterology|June 9, 2006
Safety issues with biological therapies for inflammatory bowel diseaseGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Gastroenterology Clinics of North America|November 30, 2006
Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapiesGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Pageof 29

Showing results (41-50 of 287) with videos related to

Sort By:
Pageof 29
Current Gastroenterology Reports|November 14, 2008
Optimizing treatment of inflammatory bowel diseases with biologic agentsGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Current Opinion in Gastroenterology|June 1, 2012
Classification of inflammatory bowel disease: the old and the newSeverine Vermeire, Gert Van Assche, Paul Rutgeerts
Nature Clinical Practice. Gastroenterology & Hepatology|December 6, 2005
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseasesSéverine Vermeire, Gert Van Assche, Paul Rutgeerts
Expert Opinion on Medical Diagnostics|March 19, 2013
Role of biomarkers in the diagnosis of inflammatory bowel diseaseSeverine Vermeire, Gert Van Assche, Paul Rutgeerts
Core Evidence|January 12, 2011
Infliximab: the evidence for its place in therapy in ulcerative colitisGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Gut|December 17, 2009
Predicting the response to infliximab from trough serum levelsPaul Rutgeerts, Severine Vermeire, Gert Van Assche
Inflammatory Bowel Diseases|January 19, 2007
Endoscopic therapy of strictures in Crohn's diseaseGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Inflammatory Bowel Diseases|September 26, 2008
What is the role of endoscopy in predicting Crohn's disease relapse or course?Paul Rutgeerts, Severine Vermeire, Gert Van Assche
Current Opinion in Gastroenterology|June 9, 2006
Safety issues with biological therapies for inflammatory bowel diseaseGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Gastroenterology Clinics of North America|November 30, 2006
Focus on mechanisms of inflammation in inflammatory bowel disease sites of inhibition: current and future therapiesGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Pageof 29